Vir Biotechnology, Inc. beat EPS estimates 50% of the time across 2 reported quarters (1 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $0.83 | $0.47 | -43.4% | Miss |
| Q12026 FY2026 | — | $-0.85 | — | Miss |
| Q42025 FY2025 | $-0.42 | $-0.31 | +26.2% | Beat |
Back to VIR overview · VIR holders · VIR KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.